Location: Oxford, UK

Newrotex Wins the 2026 MedTech Innovator Impact Award

We are thrilled to announce that Newrotex has been honored with the prestigious Impact Award at this Week’s MedTech Strategist Innovation Summit. 

Selected from a field of world class innovators, this award recognises Newrotex’s transformative approach to peripheral nerve repair. 

Why the Impact Award Matters

The Impact Award presented by MedTech Innovator (the world’s largest accelerator for medical device companies) focuses on patient outcomes. It is awarded to the company whose innovation has the greatest potential to fundamentally change the standard of care and improve the lives of millions. Winning this award recognises the unwavering commitment of Newrotex, to improve outcomes for patients following traumatic nerve injury. 

What’s Next?

Newrotex is currently focussed on the path to market approval and is in the final stages of preparing our IDE for submission to the FDA along with our application for Breakthrough Device Designation. We have an open fundraising round which invites investors to join us as we change the gold standard for nerve repair.  

“The Impact Award confirms what we’ve known all along: the clinical need for better nerve repair is urgent,” says Dr. Alex Woods, CEO of Newrotex. “This award provides a powerful tailwind as we close our current funding round and move into the most critical phase of our company’s history.”